Unlike cisplatin, oxaliplatin is clinically effective for the treatment of colorectal cancers; therefore, the activity of oxaliplatin was tested in 10 colorectal cancer cell lines and linked to their p53 status [141]. The gene discussed is TP53; the disease is colorectal cancer.